Estimation of cancer burden attributable to infection in Asia

Journal of Epidemiology

Volumn 25, Issue 10, 2015, Pages 626-638

  Huang, He ^a,b   Hu, Xiao Feng ^c   Zhao, Fang Hui ^a   Garland, Suzanne M ^d,e   Bhatla, Neerja ^f   Qiao, You Lin ^a  

^a CANCER HOSPITAL   (China)

^b Guizhou Center for Disease Control and Prevention   (China)

^c Institute of Occupational Health and Poison Control   (China)

^d ROYAL WOMEN'S HOSPITAL   (Australia)

^e UNIVERSITY OF MELBOURNE   (Australia)

^f ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Asia; Cancer burden; Infection; Population attributable fraction

Indexed keywords

ASIA; CAUSE OF DEATH; COMPLICATION; COST OF ILLNESS; FEMALE; HELICOBACTER INFECTIONS; HEPATITIS B; HEPATITIS C; HUMAN; INFECTION; MALE; MICROBIOLOGY; NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; RISK ASSESSMENT; TRENDS; VIROLOGY;

ASIA; CAUSE OF DEATH; COST OF ILLNESS; FEMALE; HELICOBACTER INFECTIONS; HEPATITIS B; HEPATITIS C; HUMANS; INFECTION; MALE; NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; RISK ASSESSMENT;

EID: 84958749487     PISSN: 09175040     EISSN: 13499092     Source Type: Journal    
DOI: 10.2188/jea.JE20140215     Document Type: Article

References (92)

1. Pisani P, Parkin DM, Muñoz N, Ferlay J, Maxwell D. Cancer and infection: estimates of the attributable fraction in 1990. Cancer Epidemiol Biomarkers Prev. 1997;6(6):387-400.
2. Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, ElGhissassi F, et al; WHO International Agency for Research on Cancer Monograph Working Group. A review of human carcinogens-Part B: biological agents. Lancet Oncol. 2009; 10(4):321-2.
3. de Martel C, Ferlay J, Franceschi S, Vignat J, Bray F, Forman D, et al. Global burden of cancers attributable to infections in 2008:a review and synthetic analysis. Lancet Oncol. 2012;13(6):607-15.
4. Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer. 2006;118(12):3030-44.
5. P. D. (2013). United Nations, Department of Economic and Social Affairs. World Population Prospects: The 2012 Revision, Highlights and Advance Tables. 2013.
6. International Agency for Research on Cancer. Attributable Causes of Cancer in France in the Year 2000. In: IARC Working Group Reports, Vol. 3. 2007.
7. Haque T, Iliadou P, Hossain A, Crawford DH. Seroepidemiological study of Epstein-Barr virus infection in Bangladesh. J Med Virol. 1996;48(1):17-21.
8. Ozkan A, Kilic SS, Kalkan A, Ozden M, Demirdag K, Ozdarendeli A. Seropositivity of Epstein-Barr virus in Eastern Anatolian Region of Turkey. Asian Pac J Allergy Immunol. 2003;21(1):49-53.
9. cancer_incidence (1975-2008) [Online]. Available: http:// ganjoho.jp/professional/statistics/statistics.html#01.
10. Curado M, Edwards B, Shin H, Storm H. Cancer incidence in five continents, vol. IX. 2008.
11. Shin A, Park S, Shin HR, Park EH, Park SK, Oh JK, et al. Population attributable fraction of infection-related cancers in Korea. Ann Oncol. 2011;22(6):1435-42.
12. Shin H-R, Oh J-K, Masuyer E, Curado M-P, Bouvard V, Fang Y-Y, et al. Epidemiology of cholangiocarcinoma: an update focusing on risk factors. Cancer Sci. 2010;101(3):579-85.
13. Chen F. Methods of Medical Multivariate Statistical Analysis, vol. 9, no. 3. China Statistical Publishing; 2007. p. 63-82.
14. Forman D, de Martel C, Lacey CJ, Soerjomataram I, Lortet-Tieulent J, Bruni L, et al. Global burden of human papillomavirus and related diseases. Vaccine. 2012;30 Suppl 5:F12-23.
15. Boshoff C, Weiss R. AIDS-related malignancies. Nat Rev Cancer. 2002;2(5):373-82.
16. O'Rorke MA, Ellison MV, Murray LJ, Moran M, James J, Anderson LA. Human papillomavirus related head and neck cancer survival: a systematic review and meta-analysis. Oral Oncol. 2012;48(12):1191-201.
17. D'Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007;356(19):1944-56.
18. Helicobacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut. 2001;49(3):347-53.
19. Cavaleiro-Pinto M, Peleteiro B, Lunet N, Barros H. Helicobacter pylori infection and gastric cardia cancer: systematic review and meta-analysis. Cancer Causes Control. 2011;22(3):375-87.
20. De Vuyst H, Clifford GM, Nascimento MC, Madeleine MM, Franceschi S. Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int J Cancer. 2009;124(7):1626-36.
21. Xuyu Z, Jiqian F. The application of Gibbs sampling in metaanalysis for case-control studies of HBV, HCVand dual infection in primary hepatocellular carcinoma. Acad J SUMS. 2002;23:165-9.
22. Shin HR, Oh JK, Lim MK, Shin A, Kong HJ, Jung KW, et al. Descriptive epidemiology of cholangiocarcinoma and clonorchiasis in Korea. J Korean Med Sci. 2010;25(7):1011-6.
23. Li M, Li J, Li P, Li H, Su T, Zhu R, et al. Hepatitis B virus infection increases the risk of cholangiocarcinoma: a metaanalysis and systematic review. J Gastroenterol Hepatol. 2012;27(10):1561-8.
24. Shaib YH, El-Serag HB, Davila JA, Morgan R, McGlynn KA. Risk factors of intrahepatic cholangiocarcinoma in the United States: A case-control study. Gastroenterology. 2005;128(3):620-6.
25. Haswell-Elkins MR, Mairiang E, Mairiang P, Chaiyakum J, Chamadol N, Loapaiboon V, et al. Cross-sectional study of Opisthorchis viverrini infection and cholangiocarcinoma in communities within a high-risk area in northeast Thailand. Int J Cancer. 1994;59(4):505-9.
26. Gallagher B, Wang Z, Schymura MJ, Kahn A, Fordyce EJ. Cancer incidence in New York State acquired immunodeficiency syndrome patients. Am J Epidemiol. 2001;154(6):544-56.
27. Dal Maso L, Franceschi S. Hepatitis C virus and risk of lymphoma and other lymphoid neoplasms: a meta-analysis of epidemiologic studies. Cancer Epidemiol Biomarkers Prev. 2006;15(11):2078-85.
28. Carpenter LM, Newton R, Casabonne D, Ziegler J, Mbulaiteye S, Mbidde E, et al. Antibodies against malaria and Epstein-Barr virus in childhood Burkitt lymphoma: a case-control study in Uganda. Int J Cancer. 2008;122(6):1319-23.
29. Shin HR, Lee DH, Herrero R, Smith JS, Vaccarella S, Hong SH, et al. Prevalence of human papillomavirus infection in women in Busan, South Korea. Int J Cancer. 2003;103(3):413-21.
30. Kim JH, Kim HY, Kim NY, Kim SW, Kim JG, Kim JJ, et al. Seroepidemiological study of Helicobacter pylori infection in asymptomatic people in South Korea. J Gastroenterol Hepatol. 2001;16(9):969-75.
31. Shin HR, Hwang SY, Nam CM. The prevalence of hepatitis C virus infection in Korea: pooled analysis. J Korean Med Sci. 2005;20(6):985-8.
32. Zhao FH, Lewkowitz AK, Hu SY, Chen F, Li LY, Zhang QM, et al. Prevalence of human papillomavirus and cervical intraepithelial neoplasia in China: a pooled analysis of 17 population-based studies. Int J Cancer. 2012;131(12):2929-38.
33. Wandai Z, Fulian H, Shudong X. Prevalence of Helicobacter pylori infection in China: The Team of Collaboration of Helicobacter pylori research in China. Mod Dig Interv. 2010;15(5):265-70.
34. Ministry of Health P. R. China & UNAIDS of task force in China. China's AIDS prevention and control of joint assessment report in 2003. 2003.
35. Xia G, Liu C, Caoa H, Bp S, Zhan M, Sub C, et al. Prevalence of hepatitis B and C virus infections in the general Chinese population. Results from a nationwide cross-sectional seroepidemiologic study of hepatitis A, B, C, D, and E virus infections in China, 1992. Int Hepatol Commun. 1996;5(1):62-73.
36. Inoue M, Sakaguchi J, Sasagawa T, Tango M. The evaluation of human papillomavirus DNA testing in primary screening for cervical lesions in a large Japanese population. Int J Gynecol Cancer. 2006;16(3):1007-13.
37. Moriya T, Koyama T, Tanaka J, Mishiro S, Yoshizawa H. Epidemiology of hepatitis C virus in japan. Intervirology. 1999;42(2-3):153-8.
38. UNAIDS Report on the Global AIDS Epidemic-2010 [Online]. Available: http://www.unaids.org/en/dataanalysis/ knowyourepidemic/.
39. Yamaji Y, Mitsushima T, Ikuma H, Okamoto M, Yoshida H, Kawabe T, et al. Weak response of helicobacter pylori antibody is high risk for gastric cancer: a cross-sectional study of 10 234 endoscoped Japanese. Scand J Gastroenterol. 2002;37(2):148-53.
40. Tanaka J, Kumagai J, Katayama K, Komiya Y, Mizui M, Yamanaka R, et al. Sex- and age-specific carriers of hepatitis B and C viruses in Japan estimated by the prevalence in the 3 485 648 first-time blood donors during 1995-2000. Intervirology. 2004;47(1):32-40.
41. Vet JN, de Boer MA, van den Akker BE, Siregar B, Budiningsih S, Tyasmorowati D, et al. Prevalence of human papillomavirus in Indonesia: a population-based study in three regions. Br J Cancer. 2008;99(1):214-8.
42. Tokudome S, Samsuria Soeripto WD, Triningsih FX, Suzuki S, Hosono A, Triono T, et al. Helicobacter pylori infection appears essential for stomach carcinogenesis: observations in Semarang, Indonesia. Cancer Sci. 2005;96(12):873-5.
43. Tokudome S, Triningsih FX, Ananta I, Suzuki S, Kuriki K, Akasaka S, et al. Rare infection as a factor for the very low stomach cancer incidence in Yogyakarta, Indonesia. Cancer Lett. 2005;219(1):57-61.
44. Hospital CM, Control D, Sulaiman HA, Julitasari, Sie A, RustamM, et al. Prevalence of hepatitis B and C viruses in healthy Indonesian blood donors. Trans R Soc Trop Med Hyg. 1995;89(2):167-70.
45. Shapiro CN. Epidemiology of Hepatitis. Pediatr Infect Dis J. 1993;12(5):433-7.
46. Domingo EJ, Noviani R, Noor MR, Ngelangel CA, Limpaphayom KK, Thuan TV, et al. Epidemiology and prevention of cervical cancer in Indonesia, Malaysia, the Philippines, Thailand and Vietnam. Vaccine. 2008;26 Suppl 12:M71-9.
47. Cortes MC, Yamakawa A, Casingal CR, Fajardo LS, Juan ML, De Guzman BB, et al. Diversity of the cagA gene of Helicobacter pylori strains from patients with gastroduodenal diseases in the Philippines. FEMS Immunol Med Microbiol. 2010;60(1):90-7.
48. Yanase Y, Ohida T, Kaneita Y, Agdamag DM, Leaño PS, Gill CJ. The prevalence of HIV, HBVand HCVamong Filipino blood donors and overseas work visa applicants. Bull World Health Organ. 2007;85(2):131-7.
49. Arguillas MO, Domingo EO, Tsuda F, Mayumi M, Suzuki H. Seroepidemiology of hepatitis C virus infection in the Philippines: a preliminary study and comparison with hepatitis B virus infection among blood donors, medical personnel, and patient groups in Davao, Philippines. Gastroenterol Jpn. 1991;26 Suppl 3:170-5.
50. Sukvirach S, Smith JS, Tunsakul S, Muñoz N, Kesararat V, Opasatian O, et al. Population-based human papillomavirus prevalence in Lampang and Songkla, Thailand. J Infect Dis. 2003;187(8):1246-56.
51. Perez-Perez GI, Taylor DN, Bodhidatta L, Wongsrichanalai J, Baze WB, Dunn BE, et al. Seroprevalence of Helicobacter pylori infections in Thailand. J Infect Dis. 1990;161(6):1237-41.
52. Chimparlee N, Oota S, Phikulsod S, Tangkijvanich P, Poovorawan Y, National T, et al. Review Hepatitis B and Hepatitis C Virus in Thai, 2009.
53. Merican I, Guan R, Amarapuka D, Alexander MJ, Chutaputti A, Chien RN, et al. Chronic hepatitis B virus infection in Asian countries. J Gastroenterol Hepatol. 2000;15(12):1356-61.
54. Vu LT, Bui D. Prevalence of cervical human papilloma virus infection among married women in Vietnam, 2011. Asian Pac J Cancer Prev. 2012;13(1):37-40.
55. Thu T, Hoang H, Bengtsson C, Phung DC, Sörberg M, Granström M. Seroprevalence of Helicobacter pylori Infection in Urban and Rural Vietnam Seroprevalence of Helicobacter pylori Infection in Urban and Rural Vietnam. Clin Diagn Lab Immunol. 2005;12(1):81-5.
56. Sievert W, Altraif I, Razavi HA, Abdo A, Ahmed EA, Alomair A, et al. A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt. Liver Int. 2011;31 Suppl 2:61-80.
57. Nguyen VT, Law MG, Dore GJ. An enormous hepatitis B virusrelated liver disease burden projected in Vietnam by 2025. Liver Int. 2008;28(4):525-31.
58. Ahmad MM, Rahman M, Rumi AK, Islam S, Huq F, Chowdhury MF, et al. Prevalence of Helicobacter Pylori in Asymptomatic population-a Pilot Serological Study in Bangladesh. J Epidemiol. 1997;7(4):251-4.
59. Ashraf H, Alam NH, Rothermundt C, Brooks A, Bardhan P, Hossain L, et al. Prevalence and risk factors of hepatitis B and C virus infections in an impoverished urban community in Dhaka, Bangladesh. BMC Infect Dis. 2010;10:208.
60. Rahman M, Sattar H, Rashid HA, Mollah AS. Seroepidemiological study of hepatitis B virus infection in a village. Bangladesh Medical Research Council Bulletin. 1997; 23(2):38-41.
61. Sankaranarayanan R, Chatterji R, Shastri SS, Wesley RS, Basu P, Mahe C, et al. Accuracy of human papillomavirus testing in primary screening of cervical neoplasia: results from a multicenter study in India. Int J Cancer. 2004;112(2):341-7.
62. Graham DY, Adam E, Reddy GT, Agarwal JP, Agarwal R, Evans DJ Jr, et al. Seroepidemiology of Helicobacter pylori infection in India. Comparison of developing and developed countries. Dig Dis Sci. 1991;36(8):1084-8.
63. Nanu A, Sharma SP, Chatterjee K, Jyoti P. Markers for transfusion-transmissible infections in north Indian voluntary and replacement blood donors: prevalence and trends 1989-1996. Vox Sang. 1997;73(2):70-3.
64. Tandon BN, Acharya SK, Tandon A. Epidemiology of hepatitis B virus infection in India. Gut. 1996;38 Suppl 2:S56-9.
65. Khorasanizadeh F, Hassanloo J, Khaksar N, Mohammad Taheri S, Marzaban M, Rashidi BH, et al. Epidemiology of cervical cancer and human papilloma virus infection among Iranian women-analyses of national data and systematic review of the literature. Gynecol Oncol. 2013;128(2):277-81.
66. Jafarzadeh A, Rezayati MT, Nemati M. Specific serum immunoglobulin G to H pylori and CagA in healthy children and adults (south-east of Iran). World J Gastroenterol. 2007;13(22):3117-21.
67. Merat S, Rezvan H, Nouraie M, Jafari E, Abolghasemi H, Radmard AR, et al. Seroprevalence of hepatitis C virus: the first population-based study from Iran. Int J Infect Dis. 2010;14 Suppl 3:e113-6.
68. Zali MR, Mohammad K, Noorbala AA, Noorimayer B, Shahraz S. Rate of hepatitis B seropositivity following mass vaccination in the Islamic Republic of Iran. East Mediterr Health J. 2005;11(1-2):62-7.
69. Raza SA, Franceschi S, Pallardy S, Malik FR, Avan BI, Zafar A, et al. Human papillomavirus infection in women with and without cervical cancer in Karachi, Pakistan. Br J Cancer. 2010;102(11):1657-60.
70. Rasheed F, Ahmad T, Bilal R. Frequency of Helicobacter pylori infection using 13C-UBT in asymptomatic individuals of Barakaho, Islamabad, Pakistan. J Coll Physicians Surg Pak. 2011;21(6):379-81.
71. Umar M, Bushra HT, Ahmad M, Data A, Ahmad M, Khurram M, et al. Hepatitis C in Pakistan: a review of available data. Hepat Mon. 2010;10(3):205-14.
72. Karachi, 5% of Pakistanipopulation has hepatitis B. In: A seminar on hepatitis B. 2001.
73. Özcan ES, Taşkin S, Ortaç F. High-risk human papilloma virus prevalence and its relation with abnormal cervical cytology among Turkish women. J Obstet Gynaecol. 2011;31(7):656-8.
74. Us D, Hasçelik G. Seroprevalence of Helicobacter pylori infection in an Asymptomatic Turkish population. J Infect. 1998;37(2):148-50.
75. Thomas DL, Mahley RW, Badur S, Palaoglu E, Quinn TC. The epidemiology of hepatitis C in Turkey. Infection. 1994;22(6):411-4.
76. Kuru U, Senli S, Türel L, Kuru N, Başkent A, Ulucakli O. Agespecific seroprevalence of hepatitis B virus infection. Turk J Pediatr. 1995;37(4):331-8.
77. Bondagji NS, Gazzaz FS, Sait K, Abdullah L. Prevalence of high-risk human papillomavirus infections in healthy Saudi women attending gynecologic clinics in the western region of Saudi Arabia. Ann Saudi Med. 2013;33(1):13-7.
78. Lunet N, Barros H. Helicobacter pylori infection and gastric cancer: facing the enigmas. Int J Cancer. 2003;106(6):953-60.
79. Mahaba H, el-Tayeb A-K, Elbaz H. The prevalence of antibodies to hepatitis C virus in Hail region, Saudi Arabia. J Egypt Public Health Assoc. 1999;74(1-2):69-80.
80. Bashawri LA, Fawaz NA, Ahmad MS, Qadi AA, Almawi WY. Prevalence of seromarkers of HBV and HCV among blood donors in eastern Saudi Arabia, 1998-2001. Clin Lab Haematol. 2004;26(3):225-8.
81. Mammas IN, Sourvinos G, Zaravinos A, Spandidos DA. Vaccination against human papilloma virus (HPV): epidemiological evidence of HPV in non-genital cancers. Pathol Oncol Res. 2011;17(1):103-19.
82. GLOBOCAN 2008 [Online]. Available: http://globocan.iarc.fr/ Default.aspx.
83. Miguel R, Vinita S, Ricardo I. HIV prevalence in the Asia Pacific Region: an ecological approach to inequalities. Heal Environ. 2012;1995:66-77.
84. Quinn TC. HIV series Global burden of the HIV pandemic. Lancet. 1996;348:99-106.
85. Xiang W, Shi JF, Li P, Wang JB, Xu LN, Wei WQ, et al. Estimation of cancer cases and deaths attributable to infection in China. Cancer Causes Control. 2011;22(8):1153-61.
86. Conteduca V, Sansonno D, Lauletta G, Russi S, Ingravallo G, Dammacco F. H. pylori infection and gastric cancer: state of the art (review). Int J Oncol. 2013;42(1):5-18.
87. Garland SM, Skinner SR, Brotherton JM. Adolescent and young adult HPV vaccination in Australia: achievements and challenges. Prev Med. 2011;53 Suppl 1:S29-35.
88. Lu B, Kumar A, Castellsagué X, Giuliano AR. Efficacy and safety of prophylactic vaccines against cervical HPV infection and diseases among women: a systematic review & metaanalysis. BMC Infect Dis. 2011;11(1):13.
89. Tabrizi SN, Brotherton JM, Kaldor JM, Skinner SR, Cummins E, Liu B, et al. Fall in human papillomavirus prevalence following a national vaccination program. J Infect Dis. 2012;206(11):1645-51.
90. Brotherton JM, Fridman M, May CL, Chappell G, Saville AM, Gertig DM. Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study. Lancet. 2011;377(9783):2085-92.
91. Ni YH, Huang LM, Chang MH, Yen CJ, Lu CY, You SL, et al. Two decades of universal hepatitis B vaccination in taiwan:impact and implication for future strategies. Gastroenterology. 2007;132(4):1287-93.
92. Conlan JV, Sripa B, Attwood S, Newton PN. A review of parasitic zoonoses in a changing Southeast Asia. Vet Parasitol. 2011;182(1):22-40.